Efficacy and safety of ECG-synchronized pulsatile extracorporeal membrane oxygenation in the clinical setting: The SynCor Trial.
Ingo VoigtTobias SpangenbergTareq IbrahimChristian BradaricAchim ViertelEzequiel Marcelo TalloneCarsten SkurkPeter AbelJochen GrafTorsten RinneJürgen BöhmAlexander GhanemChristoph LiebetrauPublished in: Artificial organs (2021)
The i-cor ECG-synchronized cardiac assist device appears safe and feasible showing clinical outcomes comparable to existing data in the setting of high-risk percutaneous coronary interventions and acute cardiogenic shock. Further prospective trials are warranted to identify optimal patient and interventional characteristics that will benefit most of this novel kind of mechanical circulatory support.
Keyphrases
- extracorporeal membrane oxygenation
- respiratory failure
- acute respiratory distress syndrome
- heart rate variability
- heart rate
- liver failure
- coronary artery
- coronary artery disease
- case report
- clinical trial
- electronic health record
- study protocol
- left ventricular
- minimally invasive
- mechanical ventilation
- big data
- phase iii
- drug induced
- randomized controlled trial
- aortic dissection
- hepatitis b virus
- artificial intelligence
- deep learning